CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-21 | Kinney Gene G. President and CEO | Sale | −2,720 | $32.02 | $87K | 12,793 |
| 2022-09-21 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −2,720 | 16,412 | ||
| 2022-09-21 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise | +10,000 | $6.73 | $67K | 13,200 |
| 2022-09-21 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −10,000 | $30.75 | $307K | 3,200 |
| 2022-09-21 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) | −10,000 | 60,000 | ||
| 2022-09-15 | Garren Hideki Chief Medical Officer | Option exercise | +4,000 | $24.90 | $100K | 4,000 |
| 2022-09-15 | Garren Hideki Chief Medical Officer | Sale | −4,000 | $30.00 | $120K | 0 |
| 2022-09-15 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,000 | 234,000 | ||
| 2022-08-31 | Kim Helen Susan Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-08-24 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise | +10,000 | $6.73 | $67K | 13,200 |
| 2022-08-24 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −10,000 | $30.17 | $302K | 3,200 |
| 2022-08-24 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) | −10,000 | 70,000 | ||
| 2022-08-17 | Kinney Gene G. President and CEO | Option exercise | +2,181 | $6.41 | $14K | 14,974 |
| 2022-08-17 | Kinney Gene G. President and CEO | Sale | −2,181 | $32.03 | $70K | 12,793 |
| 2022-08-17 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −2,181 | 19,132 | ||
| 2022-08-12 | Kinney Gene G. President and CEO | Option exercise | +20,284 | $6.41 | $130K | 33,077 |
| 2022-08-12 | Kinney Gene G. President and CEO | Sale | −20,284 | $32.16 | $652K | 12,793 |
| 2022-08-12 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −20,284 | 21,313 | ||
| 2022-08-11 | Kinney Gene G. President and CEO | Option exercise | +13,650 | $6.41 | $87K | 26,443 |
| 2022-08-11 | Kinney Gene G. President and CEO | Sale | −13,650 | $32.16 | $439K | 12,793 |
Page 25 of 28 · 555 trades